Patent · US Active

Sting agonists for treating bladder cancer and solid tumors

US11883420B2 · kind B2 · utility

0Cited by

1References

4Claims

0Family size

Assignee

VENENUM BIODESIGN, LLC · US

Inventors

Brian F. McGuinness · Plainsboro, US
Grant Gallagher · Milltown, US
Michael S. McQueney · Philadelphia, US
Rukiye Nazan Eraslan · Pages Corner, US
Gary L. Schieven · Seattle, US
Jason Trama · Burlington, US
Axel Metzger · Plainsboro, US
David Diller · Plainsboro, US
David E. Kaelin · Helmetta, US

Key dates

Filing date	Jun 8, 2021
Grant date	Jan 30, 2024
Priority date	—
Expiry date	Nov 6, 2041

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2039/545
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Methods for treating bladder cancer and solid tumors are disclosed. The methods include administering to a patient a compound of formula 1 Pharmaceutical compositions of compound 1 are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.